New bimetallic dicyanidoargentate(I)-based coordination compounds:Synthesis, characterization, biological activities and DNA-BSAbinding affinities      
Yazarlar (7)
Nesrin Korkmaz
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Ali Aydın
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Ahmet Karadağ
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Yusuf YANAR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Yelis Maasoğlu
Çukurova Üniversitesi, Türkiye
Ertan Şahin
Atatürk Üniversitesi, Türkiye
Şaban Tekin
Sağlık Bilimleri Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
Dergi ISSN 1386-1425 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 02-2017
Cilt No 173
Sayı 1
Sayfalar 1007 / 1022
DOI Numarası 10.1016/j.saa.2016.10.035
Makale Linki https://www.sciencedirect.com/journal/spectrochimica-acta-part-a-molecular-spectroscopy
Özet
Four compounds -two (2 and 3) completely new- of composition [Ni(edbea)Ag(CN)] (1), [Cu(edbea)Ag(CN)]·HO (2), [Cd(edbea)Ag(CN)]·HO (3) and [Cd(edbea)] [Ag(CN)]·HO (4) {edbea; 2,2'-(ethylenedioxy)bis (ethylamine)}, were synthesized and characterized using elemental, FT-IR, X-Ray (4), thermal, variable temperature magnetic measurement (1 and 2) and biological techniques. The DNA/BSA binding affinities of 2 and 3 were evaluated by UV-Vis spectrophotometric titrations, ethidium bromide exchange experiments and electrophoretic mobility measurements. Compounds 1 and 4 have previously been characterized and shown to reduce the proliferation and migration of tumor cells. For the sake of clarity, 1 precise mechanism of action on microbial organisms and temperature magnetic measurement were determined. The crystallographic analyses showed that 4 was built up of [Cd(edbea)] cations and [Ag(CN)] anions. Complexes demonstrated a remarkable antibacterial (1-4), antifungal (1-4) and antiproliferative activities (2 and 3) to ten human bacterial pathogens, four plant pathogenic fungi or three tumor cells (HeLa, HT29, and C6), respectively. Therefore, our results strongly confirm that cell proliferation, cell morphology, Bcl-2, P53 changes and apoptosis can be related to the pharmacological effects of the complexes as suitable candidate for clinical trials.
Anahtar Kelimeler
Dicyanidoargentat(I) | 2,2 '-(ethylenedioxy)bis(ethylamine) | Anticancer activity | Antimicrobial activity | Antifugal activity | Apoptosis